Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TOP1 | P11387 | 3/20 | 0.67 |
| ▸ | PPARG | P37231 | 8/20 | 0.63 |
| ▸ | PPARD | Q03181 | 7/20 | 0.63 |
| ▸ | PPARA | Q07869 | 7/20 | 0.63 |
| ▸ | PTPN1 | P18031 | 4/20 | 0.63 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.63 |
| ▸ | FABP4 | P15090 | 4/20 | 0.63 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.63 |
| ▸ | TERT | O14746 | 3/20 | 0.63 |
| ▸ | MAPT | P10636 | 3/20 | 0.63 |
| ▸ | BLM | P54132 | 3/20 | 0.63 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.63 |
| ▸ | USP2 | O75604 | 2/20 | 0.63 |
| ▸ | LMNA | P02545 | 2/20 | 0.63 |
| ▸ | RECQL | P46063 | 2/20 | 0.63 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.63 |
| ▸ | NR4A2 | P43354 | 2/20 | 0.63 |
| ▸ | GMNN | O75496 | 1/20 | 0.63 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27779756 | 0.96 | PPARG (0.69) | TOP1PPARGPPARDPPARAPTPN1 | |
| SCHEMBL28183464 | 0.96 | PPARG (0.69) | TOP1PPARGPPARDPPARAPTPN1 | |
| SCHEMBL8149939 | 0.96 | PPARG (0.69) | TOP1PPARGPPARDPPARAPTPN1 | |
| SCHEMBL9128942 | 0.96 | PPARG (0.69) | TOP1PPARGPPARDPPARAPTPN1 | |
| SCHEMBL3341235 | 0.96 | PPARG (0.69) | TOP1PPARGPPARDPPARAPTPN1 | |
| SCHEMBL29724318 | 0.96 | PPARG (0.69) | TOP1PPARGPPARDPPARAPTPN1 | |
| SCHEMBL11410056 | 0.92 | F7 (0.69) | TOP1PPARGPPARDPPARAPTPN1 | |
| SCHEMBL9632181 | 0.87 | PPARG (0.78) | TOP1PPARGPPARDPPARAPTPN1 | |
| SCHEMBL9632176 | 0.87 | PPARG (0.78) | TOP1PPARGPPARDPPARAPTPN1 | |
| SCHEMBL17540721 | 0.85 | TERT (0.48) | TOP1PPARGPPARDPPARAPTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250354174-A1 | NANOPARTICLE COMPOSITIONS CONTAINING SUGAR FUNCTIONALIZED NUCLEIC ACID CARRIERS | TIBA BIOTECH LLC (US) | 2025-11-20 | — | — | US | claimed |
| US-12410448-B2 | Nanoparticle compositions containing sugar functionalized nucleic acid carriers | TIBA BIOTECH LLC (US) | 2025-09-09 | — | — | US | claimed |
| EP-4387607-A1 | NANOPARTICLE COMPOSITIONS CONTAINING SUGAR FUNCTIONALIZED NUCLEIC ACID CARRIERS | Tiba Biotech LLC (US) | 2024-06-26 | — | — | EP | claimed |
| US-20240093238-A1 | NANOPARTICLE COMPOSITIONS CONTAINING SUGAR FUNCTIONALIZED NUCLEIC ACID CARRIERS | TIBA BIOTECH LLC (US) | 2024-03-21 | — | — | US | claimed |
| US-11859201-B2 | Nanoparticle compositions containing sugar functionalized nucleic acid carriers | TIBA BIOTECH LLC (US) | 2024-01-02 | — | — | US | claimed |
| US-20230100837-A1 | NANOPARTICLE COMPOSITIONS CONTAINING SUGAR FUNCTIONALIZED NUCLEIC ACID CARRIERS | TIBA BIOTECH LLC (US) | 2023-03-30 | — | — | US | claimed |
| WO-2023022926-A1 | NANOPARTICLE COMPOSITIONS CONTAINING SUGAR FUNCTIONALIZED NUCLEIC ACID CARRIERS | TIBA BIOTECH LLC (US) | 2023-02-23 | — | — | WO | claimed |
| US-7485759-B2 | Minimization of ligand degradation products, or reversion of same to useful phosphine ligands | DOW TECHNOLOGY INVESTMENTS LLC (US) | 2009-02-03 | — | — | US | claimed |
| US-20080114191-A1 | MINIMIZATION OF LIGAND DEGRADATION PRODUCTS, OR REVERSION OF SAME TO USEFUL PHOSPHINE LIGANDS | Union Carbide Chemicals & Plastics Technology LLC (formerly Union Carbide Chemicals & Plastics Techn (US) | 2008-05-15 | — | — | US | claimed |
| CN-1997616-A | Minimization of ligand degradation products, or conversion thereof to useful phosphine ligands | UNION CARBIDE CHEM PLASTIC (US) | 2007-07-11 | — | — | CN | claimed |
| US-20070100169-A1 | Minimization of ligand degradation products, of reversion of same to useful phosphine ligands | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY LLC | 2007-05-03 | — | — | US | claimed |
| EP-1646599-A1 | MINIMIZATION OF LIGAND DEGRADATION PRODUCTS, OR REVERSION OF SAME TO USEFUL PHOSPHINE LIGANDS | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) | 2006-04-19 | — | — | EP | claimed |
| WO-2005007602-A1 | MINIMIZATION OF LIGAND DEGRADATION PRODUCTS, OF REVERSION OF SAME TO USEFUL PHOSPHINE LIGANDS | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) | 2005-01-27 | — | — | WO | claimed |
| US-20260078086-A1 | VERSATILE BIODEGRADABLE MOLECULES AS NUCLEIC ACID CARRIERS | TIBA BIOTECH LLC (US) | 2026-03-19 | — | — | US | disclosed |
| US-20250354174-A1 | NANOPARTICLE COMPOSITIONS CONTAINING SUGAR FUNCTIONALIZED NUCLEIC ACID CARRIERS | TIBA BIOTECH LLC (US) | 2025-11-20 | — | — | US | disclosed |
| US-12410448-B2 | Nanoparticle compositions containing sugar functionalized nucleic acid carriers | TIBA BIOTECH LLC (US) | 2025-09-09 | — | — | US | disclosed |
| CN-1997616-A | Minimization of ligand degradation products, or conversion thereof to useful phosphine ligands | UNION CARBIDE CHEM PLASTIC (US) | 2007-07-11 | — | — | CN | disclosed |
| US-20070100169-A1 | Minimization of ligand degradation products, of reversion of same to useful phosphine ligands | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY LLC | 2007-05-03 | — | — | US | disclosed |
| EP-1646599-A1 | MINIMIZATION OF LIGAND DEGRADATION PRODUCTS, OR REVERSION OF SAME TO USEFUL PHOSPHINE LIGANDS | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) | 2006-04-19 | — | — | EP | disclosed |
| WO-2005007602-A1 | MINIMIZATION OF LIGAND DEGRADATION PRODUCTS, OF REVERSION OF SAME TO USEFUL PHOSPHINE LIGANDS | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) | 2005-01-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250354174-A1 | NANOPARTICLE COMPOSITIONS CONTAINING SUGAR FUNCTIONALIZED NUCLEIC ACID CARRIERS | TLR9, TLR3, TSG101 | TOP1 855/4885PPARG 3751/4885PPARD 4307/4885 |
| US-20230100837-A1 | NANOPARTICLE COMPOSITIONS CONTAINING SUGAR FUNCTIONALIZED NUCLEIC ACID CARRIERS | TLR9, TLR3, TSG101 | TOP1 855/4885PPARG 3751/4885PPARD 4307/4885 |
| US-20080114191-A1 | MINIMIZATION OF LIGAND DEGRADATION PRODUCTS, OR REVERSION OF SAME TO USEFUL PHOSPHINE LIGANDS | PHOSPHO1, FFAR4, PTGER4 | TOP1 3354/4885PPARG 79/4885PPARD 69/4885 |
| US-20070100169-A1 | Minimization of ligand degradation products, of reversion of same to useful phosphine ligands | PHOSPHO1, FFAR4, NOTUM | TOP1 3644/4885PPARG 91/4885PPARD 79/4885 |
| US-20240093238-A1 | NANOPARTICLE COMPOSITIONS CONTAINING SUGAR FUNCTIONALIZED NUCLEIC ACID CARRIERS | TLR9, TLR3, TSG101 | TOP1 855/4885PPARG 3751/4885PPARD 4307/4885 |
| US-12410448-B2 | Nanoparticle compositions containing sugar functionalized nucleic acid carriers | TLR9, TLR3, TSG101 | TOP1 855/4885PPARG 3751/4885PPARD 4307/4885 |
| US-11859201-B2 | Nanoparticle compositions containing sugar functionalized nucleic acid carriers | TLR9, TLR3, TSG101 | TOP1 855/4885PPARG 3751/4885PPARD 4307/4885 |
| US-20260078086-A1 | VERSATILE BIODEGRADABLE MOLECULES AS NUCLEIC ACID CARRIERS | NSUN2, SMC1A, SSU72 | TOP1 61/4885PPARG 3970/4885PPARD 4554/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.